Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of skin epidermis	KRT1 KRT3 KRT5 KRT76 KRT77	3.45e-09	43	28	5	GO:0030280
GeneOntologyMolecularFunction	mRNA 3'-UTR binding	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPL HNRNPA3	1.93e-06	276	28	6	GO:0003730
GeneOntologyMolecularFunction	regulatory region RNA binding	HNRNPA2B1 DHX9	1.89e-05	5	28	2	GO:0001069
GeneOntologyMolecularFunction	structural molecule activity	SHANK1 KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	2.13e-05	891	28	8	GO:0005198
GeneOntologyMolecularFunction	mRNA binding	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	3.72e-05	694	28	7	GO:0003729
GeneOntologyMolecularFunction	mRNA CDS binding	HNRNPA2B1 HNRNPL	5.28e-05	8	28	2	GO:1990715
GeneOntologyMolecularFunction	regulatory RNA binding	HNRNPA1 HNRNPA2B1 DHX9	8.84e-05	62	28	3	GO:0061980
GeneOntologyMolecularFunction	pre-mRNA binding	HNRNPA1 HNRNPA2B1 HNRNPL	9.72e-05	64	28	3	GO:0036002
GeneOntologyMolecularFunction	G-rich strand telomeric DNA binding	HNRNPA1 HNRNPA2B1	1.03e-04	11	28	2	GO:0098505
GeneOntologyMolecularFunction	single-stranded telomeric DNA binding	HNRNPA1 HNRNPA2B1	1.46e-04	13	28	2	GO:0043047
GeneOntologyMolecularFunction	pre-mRNA intronic binding	HNRNPA2B1 HNRNPL	1.71e-04	14	28	2	GO:0097157
GeneOntologyMolecularFunction	sequence-specific single stranded DNA binding	HNRNPA1 HNRNPA2B1	1.97e-04	15	28	2	GO:0098847
GeneOntologyMolecularFunction	sequence-specific mRNA binding	HNRNPA1 DHX9	3.19e-04	19	28	2	GO:1990825
GeneOntologyMolecularFunction	single-stranded DNA binding	HNRNPA1 HNRNPA2B1 DHX9	8.56e-04	134	28	3	GO:0003697
GeneOntologyMolecularFunction	telomeric DNA binding	HNRNPA1 HNRNPA2B1	1.43e-03	40	28	2	GO:0042162
GeneOntologyMolecularFunction	miRNA binding	HNRNPA1 HNRNPA2B1	2.06e-03	48	28	2	GO:0035198
GeneOntologyMolecularFunction	scaffold protein binding	SHANK1 KRT5	7.50e-03	93	28	2	GO:0097110
GeneOntologyMolecularFunction	protein methyltransferase activity	FAM98A FAM98B	9.13e-03	103	28	2	GO:0008276
GeneOntologyMolecularFunction	single-stranded RNA binding	HNRNPA1 DHX9	1.05e-02	111	28	2	GO:0003727
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	KRT5 KRT9	1.42e-02	130	28	2	GO:0005200
GeneOntologyBiologicalProcess	intermediate filament organization	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	7.03e-12	75	28	7	GO:0045109
GeneOntologyBiologicalProcess	intermediate filament cytoskeleton organization	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	5.16e-11	99	28	7	GO:0045104
GeneOntologyBiologicalProcess	intermediate filament-based process	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	5.54e-11	100	28	7	GO:0045103
GeneOntologyBiologicalProcess	keratinization	KRT1 KRT3 KRT5 KRT76 KRTAP6-1 KRT77	1.65e-09	87	28	6	GO:0031424
GeneOntologyBiologicalProcess	RNA splicing	FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.28e-08	502	28	9	GO:0008380
GeneOntologyBiologicalProcess	keratinocyte differentiation	KRT1 KRT3 KRT5 KRT76 KRTAP6-1 KRT77	1.74e-07	189	28	6	GO:0030216
GeneOntologyBiologicalProcess	skin development	KRT1 KRT3 KRT5 KRT9 KRT76 KRTAP6-1 KRT77	5.10e-07	373	28	7	GO:0043588
GeneOntologyBiologicalProcess	epidermal cell differentiation	KRT1 KRT3 KRT5 KRT76 KRTAP6-1 KRT77	1.89e-06	284	28	6	GO:0009913
GeneOntologyBiologicalProcess	epidermis development	KRT1 KRT3 KRT5 KRT9 KRT76 KRTAP6-1 KRT77	2.10e-06	461	28	7	GO:0008544
GeneOntologyBiologicalProcess	mRNA processing	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	6.79e-06	551	28	7	GO:0006397
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	7.15e-06	358	28	6	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	7.15e-06	358	28	6	GO:0000377
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	7.62e-06	362	28	6	GO:0000375
GeneOntologyBiologicalProcess	epithelial cell differentiation	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRTAP6-1 KRT77	1.42e-05	870	28	8	GO:0030855
GeneOntologyBiologicalProcess	RNA processing	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.56e-05	1500	28	10	GO:0006396
GeneOntologyBiologicalProcess	negative regulation of mRNA metabolic process	HNRNPA0 TAF15 HNRNPA2B1 DHX9	1.69e-05	115	28	4	GO:1903312
GeneOntologyBiologicalProcess	mRNA metabolic process	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	2.08e-05	917	28	8	GO:0016071
GeneOntologyBiologicalProcess	regulation of mRNA metabolic process	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPL DHX9	2.39e-05	443	28	6	GO:1903311
GeneOntologyBiologicalProcess	supramolecular fiber organization	SHANK1 KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	2.83e-05	957	28	8	GO:0097435
GeneOntologyBiologicalProcess	G-quadruplex DNA unwinding	HNRNPA2B1 DHX9	3.72e-05	7	28	2	GO:0044806
GeneOntologyBiologicalProcess	mRNA transport	HNRNPA1 HNRNPA2B1 DHX9 HNRNPA3	4.21e-05	145	28	4	GO:0051028
GeneOntologyBiologicalProcess	regulation of mRNA processing	HNRNPA1 HNRNPA2B1 HNRNPL DHX9	5.88e-05	158	28	4	GO:0050684
GeneOntologyBiologicalProcess	RNA transport	HNRNPA1 HNRNPA2B1 DHX9 HNRNPA3	8.74e-05	175	28	4	GO:0050658
GeneOntologyBiologicalProcess	nucleic acid transport	HNRNPA1 HNRNPA2B1 DHX9 HNRNPA3	8.74e-05	175	28	4	GO:0050657
GeneOntologyBiologicalProcess	establishment of RNA localization	HNRNPA1 HNRNPA2B1 DHX9 HNRNPA3	9.34e-05	178	28	4	GO:0051236
GeneOntologyBiologicalProcess	tRNA splicing, via endonucleolytic cleavage and ligation	FAM98A FAM98B	1.37e-04	13	28	2	GO:0006388
GeneOntologyBiologicalProcess	mRNA stabilization	HNRNPA0 TAF15 DHX9	1.53e-04	77	28	3	GO:0048255
GeneOntologyBiologicalProcess	RNA splicing, via endonucleolytic cleavage and ligation	FAM98A FAM98B	1.60e-04	14	28	2	GO:0000394
GeneOntologyBiologicalProcess	alternative mRNA splicing, via spliceosome	HNRNPA1 HNRNPL DHX9	1.65e-04	79	28	3	GO:0000380
GeneOntologyBiologicalProcess	regulation of RNA splicing	HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL	1.67e-04	207	28	4	GO:0043484
GeneOntologyBiologicalProcess	RNA localization	HNRNPA1 HNRNPA2B1 DHX9 HNRNPA3	2.00e-04	217	28	4	GO:0006403
GeneOntologyBiologicalProcess	negative regulation of mRNA catabolic process	HNRNPA0 TAF15 DHX9	2.20e-04	87	28	3	GO:1902373
GeneOntologyBiologicalProcess	RNA stabilization	HNRNPA0 TAF15 DHX9	2.28e-04	88	28	3	GO:0043489
GeneOntologyBiologicalProcess	RNA export from nucleus	HNRNPA1 HNRNPA2B1 DHX9	2.94e-04	96	28	3	GO:0006405
GeneOntologyBiologicalProcess	nucleobase-containing compound transport	HNRNPA1 HNRNPA2B1 DHX9 HNRNPA3	3.38e-04	249	28	4	GO:0015931
GeneOntologyBiologicalProcess	negative regulation of RNA catabolic process	HNRNPA0 TAF15 DHX9	3.42e-04	101	28	3	GO:1902369
GeneOntologyBiologicalProcess	epithelium development	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRTAP6-1 KRT77	5.56e-04	1469	28	8	GO:0060429
GeneOntologyBiologicalProcess	regulation of mRNA splicing, via spliceosome	HNRNPA1 HNRNPA2B1 HNRNPL	6.98e-04	129	28	3	GO:0048024
GeneOntologyBiologicalProcess	positive regulation of DNA metabolic process	ARID1B HNRNPA1 HNRNPA2B1 DHX9	1.01e-03	333	28	4	GO:0051054
GeneOntologyBiologicalProcess	positive regulation of telomere maintenance via telomere lengthening	HNRNPA1 HNRNPA2B1	1.28e-03	39	28	2	GO:1904358
GeneOntologyBiologicalProcess	nuclear export	HNRNPA1 HNRNPA2B1 DHX9	1.97e-03	185	28	3	GO:0051168
GeneOntologyBiologicalProcess	positive regulation of gene expression	HNRNPA0 FAM98A TAF15 ARID1B FAM98B HNRNPA1 DHX9	2.63e-03	1446	28	7	GO:0010628
GeneOntologyBiologicalProcess	regulation of alternative mRNA splicing, via spliceosome	HNRNPA1 HNRNPL	2.90e-03	59	28	2	GO:0000381
GeneOntologyBiologicalProcess	protein methylation	FAM98A FAM98B	3.61e-03	66	28	2	GO:0006479
GeneOntologyBiologicalProcess	protein alkylation	FAM98A FAM98B	3.61e-03	66	28	2	GO:0008213
GeneOntologyBiologicalProcess	regulation of telomere maintenance via telomere lengthening	HNRNPA1 HNRNPA2B1	3.94e-03	69	28	2	GO:1904356
GeneOntologyBiologicalProcess	positive regulation of telomere maintenance	HNRNPA1 HNRNPA2B1	4.28e-03	72	28	2	GO:0032206
GeneOntologyCellularComponent	intermediate filament	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRT77 KRTAP19-3 KRTAP20-2	7.42e-21	227	28	14	GO:0005882
GeneOntologyCellularComponent	intermediate filament cytoskeleton	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRT77 KRTAP19-3 KRTAP20-2	6.03e-20	263	28	14	GO:0045111
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRT77 KRTAP19-3 KRTAP20-2	1.53e-12	899	28	14	GO:0099513
GeneOntologyCellularComponent	keratin filament	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	4.06e-11	97	28	7	GO:0045095
GeneOntologyCellularComponent	supramolecular fiber	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRT77 KRTAP19-3 KRTAP20-2	5.82e-11	1179	28	14	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRT77 KRTAP19-3 KRTAP20-2	6.37e-11	1187	28	14	GO:0099081
GeneOntologyCellularComponent	tRNA-splicing ligase complex	FAM98A FAM98B	4.82e-05	8	28	2	GO:0072669
GeneOntologyCellularComponent	cornified envelope	KRT1 KRT5 KRT77	1.06e-04	69	28	3	GO:0001533
GeneOntologyCellularComponent	spliceosomal complex	HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPA3	1.84e-04	215	28	4	GO:0005681
GeneOntologyCellularComponent	catalytic step 2 spliceosome	HNRNPA1 HNRNPA2B1 HNRNPA3	2.92e-04	97	28	3	GO:0071013
GeneOntologyCellularComponent	ribonucleoprotein granule	HNRNPA2B1 HNRNPL DHX9 HNRNPA3	5.49e-04	287	28	4	GO:0035770
GeneOntologyCellularComponent	ribonucleoprotein complex	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	7.99e-04	1194	28	7	GO:1990904
HumanPheno	Ubiquitin-positive cerebral inclusion bodies	HNRNPA1 HNRNPA2B1	8.32e-06	3	9	2	HP:0012083
HumanPheno	Amyotrophic lateral sclerosis	TAF15 HNRNPA1 HNRNPA2B1	6.75e-05	49	9	3	HP:0007354
HumanPheno	Knuckle pad	KRT1 KRT9	7.73e-05	8	9	2	HP:0032541
HumanPheno	Frontotemporal dementia	TAF15 HNRNPA1 HNRNPA2B1	8.07e-05	52	9	3	HP:0002145
HumanPheno	Epidermal acanthosis	KRT1 KRT9 KRT13	9.04e-05	54	9	3	HP:0025092
HumanPheno	Calvarial hyperostosis	HNRNPA1 HNRNPA2B1	1.24e-04	10	9	2	HP:0004490
HumanPheno	Epidermal hyperkeratosis	KRT1 KRT9	1.51e-04	11	9	2	HP:0007543
HumanPheno	Palmoplantar blistering	KRT1 KRT5	1.51e-04	11	9	2	HP:0007446
HumanPheno	Diffuse palmoplantar hyperkeratosis	KRT1 KRT9	1.51e-04	11	9	2	HP:0007447
HumanPheno	Motor neuron atrophy	TAF15 HNRNPA1 HNRNPA2B1	1.65e-04	66	9	3	HP:0007373
HumanPheno	Hip pain	HNRNPA1 HNRNPA2B1	1.81e-04	12	9	2	HP:0030838
HumanPheno	Hyperkeratotic papule	KRT1 KRT5	2.14e-04	13	9	2	HP:0045059
HumanPheno	Abnormal fingernail morphology	KRT1 KRT5 KRT9 ARID1B	4.26e-04	230	9	4	HP:0001231
HumanPheno	Hyperkeratosis	KRT1 KRT5 KRT9 KRT13	4.48e-04	233	9	4	HP:0000962
HumanPheno	Hypoplastic fifth toenail	KRT5 ARID1B	4.67e-04	19	9	2	HP:0011937
HumanPheno	Abnormal epidermal morphology	KRT1 KRT9 KRT13	4.72e-04	94	9	3	HP:0011124
HumanPheno	Abnormality of keratinization	KRT1 KRT5 KRT9 KRT13	5.35e-04	244	9	4	HP:0001035
HumanPheno	Limb joint contracture	KRT1 KRT9 ARID1B HNRNPA1 HNRNPA2B1	5.97e-04	469	9	5	HP:0003121
HumanPheno	Hypergranulosis	KRT1 KRT9	6.29e-04	22	9	2	HP:0025114
HumanPheno	Dyscalculia	HNRNPA1 HNRNPA2B1	7.51e-04	24	9	2	HP:0002442
HumanPheno	Sensory neuropathy	KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1	8.28e-04	503	9	5	HP:0000763
HumanPheno	Abnormal blistering of the skin	KRT1 KRT5 KRT9	8.53e-04	115	9	3	HP:0008066
HumanPheno	Blistering by anatomical location	KRT1 KRT5	8.82e-04	26	9	2	HP:0033800
HumanPheno	EMG: chronic denervation signs	HNRNPA1 HNRNPA2B1	1.02e-03	28	9	2	HP:0003444
HumanPheno	Skin erosion	KRT1 KRT5	1.02e-03	28	9	2	HP:0200041
HumanPheno	Joint contracture of the hand	KRT1 KRT9 ARID1B HNRNPA1	1.12e-03	296	9	4	HP:0009473
HumanPheno	Abnormality of the musculature of the lower limbs	KRT5 TAF15 HNRNPA1 HNRNPA2B1	1.13e-03	297	9	4	HP:0001437
HumanPheno	Palmoplantar hyperkeratosis	KRT1 KRT5 KRT9	1.19e-03	129	9	3	HP:0000972
HumanPheno	Abnormality of the voice	KRT5 TAF15 ARID1B HNRNPA1 HNRNPA2B1	1.20e-03	545	9	5	HP:0001608
HumanPheno	Palmar hyperkeratosis	KRT1 KRT5 KRT9	1.25e-03	131	9	3	HP:0010765
HumanPheno	Plantar hyperkeratosis	KRT1 KRT5 KRT9	1.27e-03	132	9	3	HP:0007556
HumanPheno	Urinary bladder sphincter dysfunction	HNRNPA1 HNRNPA2B1	1.34e-03	32	9	2	HP:0002839
HumanPheno	Fasciculations	TAF15 HNRNPA1 HNRNPA2B1	1.39e-03	136	9	3	HP:0002380
HumanPheno	Parakeratosis	KRT5 KRT13	1.42e-03	33	9	2	HP:0001036
HumanPheno	Abnormality of temperature sensation	KRT1 KRT9	1.51e-03	34	9	2	HP:0100772
HumanPheno	Impaired temperature sensation	KRT1 KRT9	1.51e-03	34	9	2	HP:0010829
HumanPheno	Foot joint contracture	KRT1 KRT9 ARID1B HNRNPA2B1	1.76e-03	334	9	4	HP:0008366
HumanPheno	Fragile skin	KRT1 KRT5	1.79e-03	37	9	2	HP:0001030
HumanPheno	Impaired tactile sensation	KRT1 KRT9	1.79e-03	37	9	2	HP:0010830
HumanPheno	Motor axonal neuropathy	HNRNPA1 HNRNPA2B1	1.89e-03	38	9	2	HP:0007002
HumanPheno	Progressive distal muscular atrophy	TAF15 HNRNPA1	1.89e-03	38	9	2	HP:0008955
HumanPheno	Sensory axonal neuropathy	HNRNPA1 HNRNPA2B1	1.99e-03	39	9	2	HP:0003390
HumanPheno	Fatty replacement of skeletal muscle	HNRNPA1 HNRNPA2B1	1.99e-03	39	9	2	HP:0012548
HumanPheno	Dysphonia	TAF15 HNRNPA1 HNRNPA2B1	2.18e-03	159	9	3	HP:0001618
HumanPheno	Jaw hyperreflexia	TAF15 HNRNPA1	2.20e-03	41	9	2	HP:0033683
HumanPheno	Fatigable weakness of swallowing muscles	TAF15 HNRNPA1	2.30e-03	42	9	2	HP:0030195
HumanPheno	Laryngospasm	TAF15 HNRNPA1	2.30e-03	42	9	2	HP:0025425
HumanPheno	Upper-limb joint contracture	KRT1 KRT9 ARID1B HNRNPA1	2.37e-03	362	9	4	HP:0100360
HumanPheno	Hyperhidrosis	KRT1 KRT5 KRT9	2.51e-03	167	9	3	HP:0000975
HumanPheno	Abnormality of the plantar skin of foot	KRT1 KRT5 KRT9	2.69e-03	171	9	3	HP:0100872
HumanPheno	Hoffmann sign	TAF15 HNRNPA1	2.76e-03	46	9	2	HP:0031993
HumanPheno	Rimmed vacuoles	HNRNPA1 HNRNPA2B1	2.76e-03	46	9	2	HP:0003805
HumanPheno	Epidermal thickening	KRT1 KRT5 KRT9 KRT13	2.81e-03	379	9	4	HP:0011368
HumanPheno	Abnormal larynx physiology	TAF15 HNRNPA1	3.00e-03	48	9	2	HP:0025424
HumanPheno	Abnormality of the larynx	KRT5 TAF15 ARID1B HNRNPA1 HNRNPA2B1	3.01e-03	666	9	5	HP:0001600
HumanPheno	Cerebral inclusion bodies	HNRNPA1 HNRNPA2B1	3.38e-03	51	9	2	HP:0100314
HumanPheno	Cranial nerve compression	HNRNPA1 HNRNPA2B1	3.38e-03	51	9	2	HP:0001293
HumanPheno	Proximal muscle weakness in lower limbs	TAF15 HNRNPA1 HNRNPA2B1	3.42e-03	186	9	3	HP:0008994
HumanPheno	Tongue atrophy	TAF15 HNRNPA1	3.51e-03	52	9	2	HP:0012473
HumanPheno	Lower-limb joint contracture	KRT1 KRT9 ARID1B HNRNPA2B1	3.53e-03	403	9	4	HP:0005750
HumanPheno	Cranial hyperostosis	HNRNPA1 HNRNPA2B1	3.65e-03	53	9	2	HP:0004437
HumanPheno	EMG: neuropathic changes	HNRNPA1 HNRNPA2B1	3.79e-03	54	9	2	HP:0003445
HumanPheno	Abnormal skin morphology of the palm	KRT1 KRT5 KRT9 ARID1B	3.86e-03	413	9	4	HP:0040211
HumanPheno	Xerostomia	TAF15 HNRNPA1	3.93e-03	55	9	2	HP:0000217
MousePheno	hyperpigmentation	KRT1 KRT9 KRT76	3.22e-06	28	15	3	MP:0001188
MousePheno	hyperkeratosis	KRT1 KRT9 KRT76	1.11e-04	90	15	3	MP:0001242
MousePheno	abnormal esophageal epithelium morphology	KRT5 KRT13	1.45e-04	17	15	2	MP:0000468
MousePheno	abnormal epidermal layer morphology	KRT1 KRT5 KRT9 KRT76	1.59e-04	271	15	4	MP:0001216
MousePheno	abnormal tongue morphology	KRT5 KRT13 HNRNPA1	2.48e-04	118	15	3	MP:0000762
MousePheno	blistering	KRT1 KRT9	2.93e-04	24	15	2	MP:0001208
MousePheno	abnormal foot pad morphology	KRT9 KRT76	3.44e-04	26	15	2	MP:0000574
MousePheno	abnormal epidermis stratum corneum morphology	KRT1 KRT9 KRT76	3.45e-04	132	15	3	MP:0001240
MousePheno	abnormal tongue epithelium morphology	KRT5 KRT13	3.71e-04	27	15	2	MP:0000764
MousePheno	abnormal long-term spatial reference memory	SHANK1 ARID1B	8.60e-04	41	15	2	MP:0008432
MousePheno	acanthosis	KRT1 KRT9	9.46e-04	43	15	2	MP:0001874
MousePheno	epidermis stratum spinosum hyperplasia	KRT1 KRT9	1.04e-03	45	15	2	MP:0009611
Domain	KRTAP	KRTAP19-1 KRTAP19-8 KRTAP19-5 KRTAP20-1 KRTAP19-3 KRTAP20-2	2.49e-14	15	27	6	PF11759
Domain	KRTAP_type6/8/16/19/20/21	KRTAP19-1 KRTAP19-8 KRTAP19-5 KRTAP20-1 KRTAP19-3 KRTAP20-2	2.49e-14	15	27	6	IPR021743
Domain	Intermediate_filament_CS	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	2.97e-12	63	27	7	IPR018039
Domain	Filament	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	7.08e-12	71	27	7	SM01391
Domain	IF	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	7.83e-12	72	27	7	PS00226
Domain	Filament	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	8.66e-12	73	27	7	PF00038
Domain	IF	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	1.16e-11	76	27	7	IPR001664
Domain	Keratin_I	KRT1 KRT3 KRT9 KRT13 KRT76 KRT77	3.42e-11	44	27	6	IPR002957
Domain	Keratin_2_head	KRT1 KRT3 KRT5 KRT76 KRT77	1.78e-10	24	27	5	IPR032444
Domain	Keratin_2_head	KRT1 KRT3 KRT5 KRT76 KRT77	1.78e-10	24	27	5	PF16208
Domain	Keratin_II	KRT1 KRT3 KRT5 KRT76 KRT77	2.75e-10	26	27	5	IPR003054
Domain	RRM_1	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.41e-08	208	27	7	PF00076
Domain	RRM	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.89e-08	217	27	7	SM00360
Domain	RRM_dom	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.58e-08	227	27	7	IPR000504
Domain	RRM	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.82e-08	230	27	7	PS50102
Domain	-	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	4.24e-08	244	27	7	3.30.70.330
Domain	Nucleotide-bd_a/b_plait	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	6.21e-08	258	27	7	IPR012677
Domain	GrpE_coiled_coil	KRT3 KRT76 KRT77	5.88e-07	12	27	3	IPR013805
Domain	HnRNPA1	HNRNPA1 HNRNPA2B1	6.03e-06	3	27	2	PF11627
Domain	Uncharacterised_FAM98	FAM98A FAM98B	6.03e-06	3	27	2	IPR018797
Domain	HnRNPA1	HNRNPA1 HNRNPA2B1	6.03e-06	3	27	2	IPR021662
Domain	DUF2465	FAM98A FAM98B	6.03e-06	3	27	2	PF10239
Domain	HR1_rho-bd	KRT3 KRT77	5.92e-04	25	27	2	IPR011072
Domain	Homeobox_metazoa	NKX2-3 HOXA10	7.45e-03	90	27	2	IPR020479
Pathway	REACTOME_KERATINIZATION	KRT1 KRT5 KRT9 KRT13 KRT76 KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRT77 KRTAP19-3 KRTAP20-2	8.03e-20	153	25	13	MM15343
Pathway	REACTOME_KERATINIZATION	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRT77 KRTAP19-3 KRTAP20-2	1.06e-19	217	25	14	M27640
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	KRT1 KRT5 KRT9 KRT13 KRT76 KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRT77 KRTAP19-3 KRTAP20-2	4.47e-13	502	25	13	MM14537
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	KRT1 KRT3 KRT5 KRT9 KRT13 ARID1B KRT76 KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRT77 KRTAP19-3 KRTAP20-2	1.44e-09	1432	25	15	M509
Pathway	REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	1.91e-09	129	25	7	M27649
Pathway	REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE	KRT1 KRT5 KRT9 KRT13 KRT76 KRT77	7.48e-09	87	25	6	MM15351
Pathway	WP_MRNA_PROCESSING	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	9.54e-06	451	25	7	MM15946
Pathway	REACTOME_MRNA_SPLICING	HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	2.36e-05	201	25	5	MM15411
Pathway	REACTOME_MRNA_SPLICING	HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	3.05e-05	212	25	5	M14033
Pathway	WP_MRNA_PROCESSING	HNRNPA1 HNRNPA2B1 HNRNPL DHX9	6.65e-05	126	25	4	M39406
Pathway	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	1.09e-04	277	25	5	MM15414
Pathway	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	1.20e-04	283	25	5	M13087
Pathway	REACTOME_METABOLISM_OF_RNA	FAM98B HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	1.37e-03	724	25	6	M16843
Pathway	REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN	KRT1 KRT5	2.26e-03	40	25	2	M48231
Pathway	REACTOME_METABOLISM_OF_RNA	HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	3.91e-03	612	25	5	MM15547
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	HNRNPA0 KRT1 KRT3 KRT5 KRT9 KRT13 FAM98A TAF15 HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.03e-19	605	28	15	28977666
Pubmed	hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling.	HNRNPA0 KRT1 KRT5 KRT9 KRT13 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	2.44e-19	346	28	13	25324306
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	HNRNPA0 KRT1 KRT3 KRT5 KRT9 KRT13 FAM98A TAF15 ARID1B KRT76 HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPL DHX9 HNRNPA3	9.57e-19	1153	28	17	29845934
Pubmed	Krtap16, characterization of a new hair keratin-associated protein (KAP) gene complex on mouse chromosome 16 and evidence for regulation by Hoxc13.	KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRTAP19-3 KRTAP20-2	1.88e-18	17	28	7	15385554
Pubmed	Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.	HNRNPA0 HOXA10 KRT1 KRT5 KRT9 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	3.16e-18	421	28	13	34650049
Pubmed	TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.	HNRNPA0 HOXA10 KRT1 KRT5 KRT9 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	4.17e-18	430	28	13	38172120
Pubmed	Prothymosin-α enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer.	KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 HNRNPA3	2.04e-14	24	28	6	30719818
Pubmed	RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers.	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	2.50e-14	57	28	7	31862882
Pubmed	New consensus nomenclature for mammalian keratins.	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	5.21e-14	63	28	7	16831889
Pubmed	The necdin interactome: evaluating the effects of amino acid substitutions and cell stress using proximity-dependent biotinylation (BioID) and mass spectrometry.	HNRNPA0 KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	5.82e-14	330	28	10	32529326
Pubmed	Isolation and characterization of mouse high-glycine/tyrosine proteins.	KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP19-3	5.83e-14	10	28	5	9374545
Pubmed	Molecular evolution of the keratin associated protein gene family in mammals, role in the evolution of mammalian hair.	KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRTAP19-3 KRTAP20-2	1.01e-13	69	28	7	18721477
Pubmed	Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.	HNRNPA0 KRT5 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.29e-13	136	28	8	26979993
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	HNRNPA0 KRT1 KRT9 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.38e-13	725	28	12	27025967
Pubmed	Overexpression of Hoxc13 in differentiating keratinocytes results in downregulation of a novel hair keratin gene cluster and alopecia.	KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP19-3	1.83e-13	12	28	5	11290294
Pubmed	A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis.	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.14e-13	254	28	9	28431233
Pubmed	Characterization of a first domain of human high glycine-tyrosine and high sulfur keratin-associated protein (KAP) genes on chromosome 21q22.1.	KRTAP19-1 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRTAP19-3 KRTAP20-2	5.78e-13	40	28	6	12359730
Pubmed	A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer.	HNRNPA0 KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	9.13e-13	286	28	9	32041737
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	HNRNPA0 KRT1 KRT5 KRT9 TAF15 FAM98B HNRNPA1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.24e-12	641	28	11	36057605
Pubmed	Revealing A-Raf functions through its interactome.	HNRNPA0 KRT1 KRT5 KRT9 TAF15 HNRNPA1 HNRNPH3 DHX9	1.70e-12	187	28	8	29777862
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	HNRNPA0 KRT1 KRT5 KRT9 FAM98A ARID1B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	2.31e-12	922	28	12	27609421
Pubmed	Integrative genomics positions MKRN1 as a novel ribonucleoprotein within the embryonic stem cell gene regulatory network.	FAM98A HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	3.04e-12	52	28	6	26265008
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	HNRNPA0 KRT1 KRT3 KRT5 KRT9 KRT13 HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPL DHX9 HNRNPA3	3.82e-12	1257	28	13	36526897
Pubmed	Cellular redox sensor HSCARG negatively regulates the translesion synthesis pathway and exacerbates mammary tumorigenesis.	HNRNPA0 KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPA3	6.52e-12	221	28	8	31796584
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPL DHX9 HNRNPA3	9.33e-12	551	28	10	34728620
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.44e-11	244	28	8	29884807
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	HNRNPA0 KRT1 KRT5 KRT9 TAF15 ARID1B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.49e-11	1082	28	12	38697112
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	HNRNPA0 KRT1 KRT5 KRT9 KRT13 FAM98A FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.68e-11	1415	28	13	28515276
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	HNRNPA0 KRT1 KRT3 KRT5 KRT13 FAM98A TAF15 KRT76 FAM98B HNRNPA1 HNRNPA2B1 KRT77 HNRNPA3	2.12e-11	1442	28	13	35575683
Pubmed	The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation.	HNRNPA0 KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	2.30e-11	604	28	10	37616343
Pubmed	Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.	HNRNPA0 FAM98A HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	2.39e-11	260	28	8	36199071
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	HNRNPA0 FAM98A TAF15 ARID1B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	2.74e-11	615	28	10	31048545
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	HNRNPA0 HOXA10 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	4.36e-11	441	28	9	31239290
Pubmed	Proteomic analysis of complexes formed by human topoisomerase I.	HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	4.60e-11	32	28	5	15848144
Pubmed	Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes.	KRT1 KRT3 KRT5 KRT9 KRT13 KRT77	5.97e-11	84	28	6	29563501
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	HNRNPA0 KRT1 KRT9 KRT13 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPL DHX9	7.10e-11	678	28	10	30209976
Pubmed	Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	7.95e-11	88	28	6	26318153
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	HNRNPA0 FAM98A TAF15 ARID1B FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	8.76e-11	954	28	11	36373674
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	HNRNPA0 KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.07e-10	707	28	10	19738201
Pubmed	Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.	HNRNPA2B1 HNRNPH3 HNRNPL DHX9	1.10e-10	11	28	4	21900255
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	HNRNPA0 KRT1 KRT9 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	1.13e-10	711	28	10	33022573
Pubmed	A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications.	FAM98A HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	1.27e-10	95	28	6	37211047
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	HNRNPA0 KRT1 KRT9 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.45e-10	1318	28	12	30463901
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	HNRNPA0 HOXA10 KRT5 KRT9 TAF15 HNRNPA2B1 DHX9 HNRNPA3	2.01e-10	340	28	8	29478914
Pubmed	Comprehensive proteomic analysis of the human spliceosome.	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	2.94e-10	109	28	6	12226669
Pubmed	Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPH3 DHX9 HNRNPA3	2.94e-10	109	28	6	29511296
Pubmed	SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication.	HNRNPA0 FAM98A FAM98B HNRNPA1 HNRNPA2B1 DHX9 HNRNPA3	3.43e-10	216	28	7	37640791
Pubmed	SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.	KRT1 KRT5 KRT9 KRT13 FAM98B HNRNPA1 KRT77 HNRNPL DHX9	3.48e-10	558	28	9	27591049
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPL DHX9 HNRNPA3	3.67e-10	803	28	10	36517590
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SHANK1 HNRNPA0 KRT1 KRT5 FAM98A TAF15 KRT76 FAM98B HNRNPA1 HNRNPA2B1 DHX9 HNRNPA3	3.71e-10	1431	28	12	37142655
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	3.85e-10	807	28	10	22681889
Pubmed	Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis.	HNRNPA1 HNRNPA2B1 HNRNPA3	4.67e-10	3	28	3	23827524
Pubmed	LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.	HNRNPA0 KRT1 KRT5 KRT9 FAM98A HNRNPA1 HNRNPA2B1 KRT77 DHX9	4.89e-10	580	28	9	35676659
Pubmed	Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL.	HNRNPA1 HNRNPA2B1 KRT77 HNRNPL DHX9 HNRNPA3	6.12e-10	123	28	6	35583604
Pubmed	DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer.	KRT1 KRT5 KRT9 KRT13 HNRNPA1 HNRNPA2B1 KRT77	6.74e-10	238	28	7	35864588
Pubmed	Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.	HNRNPA0 HOXA10 HNRNPA1 HNRNPH3 HNRNPL DHX9	8.95e-10	131	28	6	34551306
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	KRT1 KRT5 KRT9 FAM98A HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	9.53e-10	626	28	9	33644029
Pubmed	Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.	HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.03e-09	58	28	5	30009671
Pubmed	E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis.	KRT1 KRT5 KRT9 KRT13 HNRNPA1 HNRNPA2B1	1.07e-09	135	28	6	29859926
Pubmed	Landscape of the SOX2 protein-protein interactome.	FAM98A TAF15 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	1.12e-09	136	28	6	21280222
Pubmed	RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.	HNRNPA0 KRT1 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 DHX9 HNRNPA3	1.17e-09	425	28	8	21081503
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	HNRNPA0 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.18e-09	258	28	7	37794589
Pubmed	Identification of novel keratinocyte-secreted peptides dermokine-alpha/-beta and a new stratified epithelium-secreted protein gene complex on human chromosome 19q13.1.	KRTAP19-1 KRTAP19-8 KRTAP19-5 KRTAP19-3	1.29e-09	19	28	4	15234001
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	HNRNPA0 KRT1 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.36e-09	652	28	9	31180492
Pubmed	Charting the molecular network of the drug target Bcr-Abl.	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	1.46e-09	266	28	7	19380743
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.79e-09	274	28	7	34244482
Pubmed	Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs.	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	2.43e-09	22	28	4	12456657
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	2.97e-09	713	28	9	29802200
Pubmed	LINKIN, a new transmembrane protein necessary for cell adhesion.	HNRNPA0 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	3.03e-09	480	28	8	25437307
Pubmed	Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances Osteoclastogenesis.	KRT1 KRT3 KRT5 KRT9	3.53e-09	24	28	4	27507811
Pubmed	Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.	HNRNPA0 KRT1 KRT9 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.62e-09	491	28	8	22623428
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	HNRNPA0 FAM98A TAF15 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	3.79e-09	494	28	8	26831064
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	HNRNPA0 KRT5 TAF15 HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPL DHX9 HNRNPA3	3.80e-09	1024	28	10	24711643
Pubmed	Beads-free protein immunoprecipitation for a mass spectrometry-based interactome and posttranslational modifications analysis.	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	4.61e-09	172	28	6	26336360
Pubmed	Integrative analysis of the ubiquitin proteome isolated using Tandem Ubiquitin Binding Entities (TUBEs).	HNRNPA2B1 HNRNPL DHX9 HNRNPA3	6.79e-09	28	28	4	22178446
Pubmed	ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.	KRT1 KRT9 TAF15 HNRNPA1 HNRNPA2B1 DHX9 HNRNPA3	7.34e-09	336	28	7	31253590
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	7.96e-09	340	28	7	24332808
Pubmed	The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.	HNRNPA0 FAM98B HNRNPA1 HNRNPA2B1 KRT77 HNRNPL DHX9 HNRNPA3	9.00e-09	552	28	8	36293380
Pubmed	Identifying and quantifying in vivo methylation sites by heavy methyl SILAC.	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1	9.07e-09	30	28	4	15782174
Pubmed	Dynamic remodelling of human 7SK snRNP controls the nuclear level of active P-TEFb.	HNRNPA1 HNRNPA2B1 DHX9	9.33e-09	6	28	3	17611602
Pubmed	Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.	HNRNPA0 HNRNPH3 HNRNPL DHX9 HNRNPA3	9.72e-09	90	28	5	23151878
Pubmed	TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity.	KRT1 KRT5 KRT9 KRT13 KRT77	1.03e-08	91	28	5	34445801
Pubmed	SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.	KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL	1.03e-08	353	28	7	27545878
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	KRT5 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	1.28e-08	844	28	9	25963833
Pubmed	Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production.	FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 DHX9 HNRNPA3	1.36e-08	206	28	6	22174317
Pubmed	Molecular composition of IMP1 ribonucleoprotein granules.	HNRNPA1 HNRNPA2B1 HNRNPL DHX9	1.94e-08	36	28	4	17289661
Pubmed	KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer.	KRT1 KRT9 HNRNPA1 HNRNPA2B1 DHX9	2.02e-08	104	28	5	36055981
Pubmed	Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.	HNRNPA0 FAM98A HNRNPA1 HNRNPA2B1 DHX9 HNRNPA3	2.18e-08	223	28	6	20020773
Pubmed	Transcriptome and phenotypic analysis reveals Gata3-dependent signalling pathways in murine hair follicles.	KRTAP19-1 KRTAP19-8 KRTAP19-5 KRTAP19-3	2.18e-08	37	28	4	17151017
Pubmed	FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis.	KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 HNRNPA3	2.23e-08	224	28	6	28443643
Pubmed	Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing.	HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.20e-08	114	28	5	31553912
Pubmed	Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease.	KRT1 KRT5 KRT9 FAM98A HNRNPA2B1 HNRNPL DHX9	3.28e-08	418	28	7	32552912
Pubmed	The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	3.28e-08	239	28	6	26641092
Pubmed	Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1.	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPH3 DHX9 HNRNPA3	3.45e-08	241	28	6	23125841
Pubmed	Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology.	TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 DHX9 HNRNPA3	3.62e-08	243	28	6	36964488
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	HNRNPA0 KRT5 KRT13 FAM98A FAM98B HNRNPL DHX9 HNRNPA3	3.80e-08	665	28	8	30457570
Pubmed	Characterization of new members of the human type II keratin gene family and a general evaluation of the keratin gene domain on chromosome 12q13.13.	KRT3 KRT76 KRT77	3.91e-08	9	28	3	15737194
Pubmed	Affinity purification of ARE-binding proteins identifies polyA-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization.	HNRNPA0 HNRNPA1 HNRNPA2B1	3.91e-08	9	28	3	12565831
Pubmed	Identification of new mechanisms of cellular response to chemotherapy by tracking changes in post-translational modifications by ubiquitin and ubiquitin-like proteins.	HNRNPA2B1 HNRNPH3 DHX9 HNRNPA3	4.89e-08	45	28	4	24654937
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	4.98e-08	989	28	9	36424410
Interaction	HEXIM1 interactions	HNRNPA0 KRT1 KRT3 KRT5 KRT9 KRT13 FAM98A TAF15 ARID1B KRT76 HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPL DHX9 HNRNPA3	9.48e-18	913	25	17	int:HEXIM1
Interaction	CUL5 interactions	HNRNPA0 KRT1 KRT3 KRT5 KRT9 KRT13 FAM98A TAF15 HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.15e-17	567	25	15	int:CUL5
Interaction	MIR138-1 interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	6.40e-17	68	25	9	int:MIR138-1
Interaction	MIR7-3 interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.84e-16	76	25	9	int:MIR7-3
Interaction	MIR16-1 interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.84e-16	76	25	9	int:MIR16-1
Interaction	MIR199A2 interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.84e-16	76	25	9	int:MIR199A2
Interaction	COPS5 interactions	HNRNPA0 HOXA10 KRT1 KRT3 KRT5 KRT9 KRT13 FAM98A TAF15 KRT76 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	2.21e-16	1102	25	17	int:COPS5
Interaction	MIR222 interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.65e-16	79	25	9	int:MIR222
Interaction	CAND1 interactions	HNRNPA0 KRT1 KRT5 KRT9 KRT13 FAM98A TAF15 ARID1B KRT76 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	2.77e-16	894	25	16	int:CAND1
Interaction	MIR10B interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.77e-16	82	25	9	int:MIR10B
Interaction	MIR106A interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	4.22e-16	83	25	9	int:MIR106A
Interaction	MIR200B interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	4.73e-16	84	25	9	int:MIR200B
Interaction	MIR18B interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	5.28e-16	85	25	9	int:MIR18B
Interaction	MIR9-1 interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	5.28e-16	85	25	9	int:MIR9-1
Interaction	MIR141 interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	7.31e-16	88	25	9	int:MIR141
Interaction	CUL2 interactions	HNRNPA0 KRT1 KRT5 KRT9 KRT13 FAM98A TAF15 ARID1B KRT76 HNRNPA1 HNRNPA2B1 HNRNPH3 DHX9 HNRNPA3	9.90e-16	591	25	14	int:CUL2
Interaction	MIR200C interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.00e-15	91	25	9	int:MIR200C
Interaction	MIR205 interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.23e-15	93	25	9	int:MIR205
Interaction	TRIM31 interactions	HNRNPA0 HOXA10 KRT1 KRT5 KRT9 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.32e-15	454	25	13	int:TRIM31
Interaction	MIRLET7F1 interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.36e-15	94	25	9	int:MIRLET7F1
Interaction	MIRLET7A2 interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.65e-15	96	25	9	int:MIRLET7A2
Interaction	MIRLET7F2 interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.82e-15	97	25	9	int:MIRLET7F2
Interaction	MIR34A interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.48e-15	104	25	9	int:MIR34A
Interaction	MIRLET7E interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	4.15e-15	106	25	9	int:MIRLET7E
Interaction	MIRLET7A1 interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	4.93e-15	108	25	9	int:MIRLET7A1
Interaction	MIRLET7G interactions	HNRNPA0 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.04e-14	117	25	9	int:MIRLET7G
Interaction	NEDD8 interactions	HNRNPA0 KRT1 KRT5 KRT9 KRT13 TAF15 KRT76 HNRNPA1 HNRNPA2B1 HNRNPH3 DHX9 HNRNPA3	1.06e-14	393	25	12	int:NEDD8
Interaction	MIR9-3 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.45e-14	70	25	8	int:MIR9-3
Interaction	MIR140 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.63e-14	71	25	8	int:MIR140
Interaction	MIR18A interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.05e-14	73	25	8	int:MIR18A
Interaction	MIR29B1 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.05e-14	73	25	8	int:MIR29B1
Interaction	MIR20A interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.30e-14	74	25	8	int:MIR20A
Interaction	MIR15A interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.57e-14	75	25	8	int:MIR15A
Interaction	CHD3 interactions	HNRNPA0 KRT1 KRT3 KRT5 KRT9 FAM98A TAF15 HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPL DHX9 HNRNPA3	3.00e-14	757	25	14	int:CHD3
Interaction	MIR9-2 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.21e-14	77	25	8	int:MIR9-2
Interaction	MIR200A interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.21e-14	77	25	8	int:MIR200A
Interaction	MIR98 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.57e-14	78	25	8	int:MIR98
Interaction	MIR1-2 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.97e-14	79	25	8	int:MIR1-2
Interaction	MIR34C interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.97e-14	79	25	8	int:MIR34C
Interaction	MIR143 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	4.41e-14	80	25	8	int:MIR143
Interaction	MIR145 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	4.89e-14	81	25	8	int:MIR145
Interaction	MIR31 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	6.61e-14	84	25	8	int:MIR31
Interaction	MIR7-2 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	6.61e-14	84	25	8	int:MIR7-2
Interaction	MIR199A1 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	6.61e-14	84	25	8	int:MIR199A1
Interaction	MIR107 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	7.29e-14	85	25	8	int:MIR107
Interaction	MIR17 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	7.29e-14	85	25	8	int:MIR17
Interaction	MIR93 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	7.29e-14	85	25	8	int:MIR93
Interaction	MIR16-2 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	7.29e-14	85	25	8	int:MIR16-2
Interaction	MIR20B interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	8.03e-14	86	25	8	int:MIR20B
Interaction	MIR29A interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	8.84e-14	87	25	8	int:MIR29A
Interaction	MIR29C interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.07e-13	89	25	8	int:MIR29C
Interaction	MIR221 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.17e-13	90	25	8	int:MIR221
Interaction	MIR92A2 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.17e-13	90	25	8	int:MIR92A2
Interaction	MIR155 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.40e-13	92	25	8	int:MIR155
Interaction	MIR128-1 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.40e-13	92	25	8	int:MIR128-1
Interaction	MIR214 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.53e-13	93	25	8	int:MIR214
Interaction	MIR19B2 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.67e-13	94	25	8	int:MIR19B2
Interaction	MIRLET7C interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.17e-13	97	25	8	int:MIRLET7C
Interaction	MIR21 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.17e-13	97	25	8	int:MIR21
Interaction	MIR363 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.17e-13	97	25	8	int:MIR363
Interaction	MIR128-2 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.57e-13	99	25	8	int:MIR128-2
Interaction	MIR19A interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.79e-13	100	25	8	int:MIR19A
Interaction	MIRLET7B interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.02e-13	101	25	8	int:MIRLET7B
Interaction	MIRLET7D interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.02e-13	101	25	8	int:MIRLET7D
Interaction	MIR25 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.02e-13	101	25	8	int:MIR25
Interaction	MIRLET7A3 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.28e-13	102	25	8	int:MIRLET7A3
Interaction	MIR15B interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.55e-13	103	25	8	int:MIR15B
Interaction	MIR7-1 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.55e-13	103	25	8	int:MIR7-1
Interaction	MIR19B1 interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.85e-13	104	25	8	int:MIR19B1
Interaction	DCUN1D1 interactions	KRT1 KRT5 KRT9 TAF15 HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 DHX9 HNRNPA3	5.19e-13	275	25	10	int:DCUN1D1
Interaction	CHD4 interactions	HNRNPA0 KRT1 KRT3 KRT5 KRT9 KRT13 TAF15 HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPL DHX9 HNRNPA3	5.62e-13	938	25	14	int:CHD4
Interaction	MIR34B interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	6.09e-13	110	25	8	int:MIR34B
Interaction	MIRLET7I interactions	HNRNPA0 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	8.16e-13	114	25	8	int:MIRLET7I
Interaction	MIR122 interactions	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.27e-12	71	25	7	int:MIR122
Interaction	MIR29B2 interactions	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.27e-12	71	25	7	int:MIR29B2
Interaction	RNF208 interactions	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	3.38e-12	75	25	7	int:RNF208
Interaction	MIR429 interactions	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.72e-12	76	25	7	int:MIR429
Interaction	MIR92A1 interactions	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	4.49e-12	78	25	7	int:MIR92A1
Interaction	MIR451A interactions	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	4.49e-12	78	25	7	int:MIR451A
Interaction	MIR206 interactions	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	4.92e-12	79	25	7	int:MIR206
Interaction	MYCN interactions	HNRNPA0 KRT1 KRT5 KRT9 FAM98A TAF15 ARID1B FAM98B HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPL DHX9 HNRNPA3	5.01e-12	1373	25	15	int:MYCN
Interaction	ACE2 interactions	SHANK1 HNRNPA0 KRT1 KRT5 KRT9 FAM98A TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	5.24e-12	1106	25	14	int:ACE2
Interaction	CUL1 interactions	HNRNPA0 KRT1 KRT5 KRT9 KRT13 FAM98A TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	5.80e-12	876	25	13	int:CUL1
Interaction	MIR138-2 interactions	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.07e-11	88	25	7	int:MIR138-2
Interaction	MIR1-1 interactions	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.26e-11	90	25	7	int:MIR1-1
Interaction	CUL4B interactions	HNRNPA0 KRT1 KRT5 KRT9 KRT13 TAF15 KRT76 HNRNPA1 HNRNPA2B1 HNRNPH3 DHX9 HNRNPA3	1.52e-11	728	25	12	int:CUL4B
Interaction	MIR106B interactions	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.31e-11	98	25	7	int:MIR106B
Interaction	NDN interactions	HNRNPA0 KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	7.21e-11	453	25	10	int:NDN
Interaction	RBM45 interactions	HNRNPA0 KRT5 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.01e-10	207	25	8	int:RBM45
Interaction	MEPCE interactions	HNRNPA0 KRT1 KRT5 KRT9 KRT13 TAF15 KRT76 HNRNPA1 HNRNPA2B1 KRT77 DHX9 HNRNPA3	1.04e-10	859	25	12	int:MEPCE
Interaction	LARP7 interactions	HNRNPA0 KRT1 KRT3 KRT5 KRT9 TAF15 KRT76 HNRNPA1 HNRNPA2B1 KRT77 HNRNPL DHX9 HNRNPA3	1.16e-10	1113	25	13	int:LARP7
Interaction	FBP1 interactions	HNRNPA0 KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 HNRNPL DHX9 HNRNPA3	1.97e-10	348	25	9	int:FBP1
Interaction	HNRNPA1 interactions	HNRNPA0 KRT1 KRT5 KRT9 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	3.12e-10	945	25	12	int:HNRNPA1
Interaction	TNIP2 interactions	HNRNPA0 KRT1 KRT5 KRT9 FAM98A ARID1B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	3.39e-10	952	25	12	int:TNIP2
Interaction	NMRAL1 interactions	HNRNPA0 KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPA3	3.73e-10	244	25	8	int:NMRAL1
Interaction	KRT17 interactions	KRT1 KRT5 KRT9 KRT13 KRT76 HNRNPA1 HNRNPA2B1 KRT77	4.81e-10	252	25	8	int:KRT17
Interaction	KRT25 interactions	KRT1 KRT3 KRT5 KRT76 KRT77	6.08e-10	35	25	5	int:KRT25
Interaction	RPS6KB2 interactions	KRT1 KRT5 KRT9 KRT13 TAF15 HNRNPA1 HNRNPA2B1 DHX9	6.36e-10	261	25	8	int:RPS6KB2
Interaction	ANKRD12 interactions	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPL HNRNPA3	8.15e-10	37	25	5	int:ANKRD12
Interaction	MIDN interactions	HNRNPA0 KRT1 KRT5 KRT9 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL DHX9 HNRNPA3	1.67e-09	626	25	10	int:MIDN
Cytoband	21q22.1	KRTAP19-1 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRTAP19-3 KRTAP20-2	9.33e-14	39	28	6	21q22.1
Cytoband	12q13.13	KRT1 KRT3 KRT5 KRT76 KRT77	5.44e-10	67	28	5	12q13.13
Cytoband	Ensembl 112 genes in cytogenetic band chr21q22	KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRTAP19-3 KRTAP20-2	2.43e-09	377	28	7	chr21q22
Cytoband	Ensembl 112 genes in cytogenetic band chr12q13	KRT1 KRT3 KRT5 KRT76 HNRNPA1 KRT77	1.87e-07	423	28	6	chr12q13
Cytoband	Ensembl 112 genes in cytogenetic band chr7p15	HOXA10 HNRNPA2B1	1.75e-03	101	28	2	chr7p15
GeneFamily	Keratin associated proteins	KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP20-1 KRTAP19-3 KRTAP20-2	1.43e-10	109	26	7	619
GeneFamily	Keratins, type II	KRT1 KRT3 KRT5 KRT76 KRT77	3.23e-10	27	26	5	609
GeneFamily	RNA binding motif containing	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.55e-08	213	26	7	725
GeneFamily	Keratins, type I	KRT9 KRT13	7.35e-04	28	26	2	608
Coexpression	HOLLERN_SQUAMOUS_BREAST_TUMOR	KRT1 KRT5 KRTAP19-1 KRTAP19-8 KRTAP6-1 KRTAP19-5 KRTAP19-3	1.61e-09	204	28	7	MM966
Coexpression	FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPH3 DHX9 HNRNPA3	2.57e-06	380	28	6	M41703
Coexpression	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	HOXA10 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 DHX9 HNRNPA3	5.08e-06	669	28	7	M18635
Coexpression	HAY_BONE_MARROW_PRO_B	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPA3	1.60e-05	304	28	5	M39208
Coexpression	LIU_CDX2_TARGETS_DN	KRT1 KRT9	3.07e-05	8	28	2	M19218
Coexpression	HOLLERN_SQUAMOUS_BREAST_TUMOR	KRT1 KRT5 KRTAP19-8 KRTAP19-3	3.32e-05	173	28	4	M650
Coexpression	GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN	HOXA10 ARID1B HNRNPA2B1 HNRNPH3	4.22e-05	184	28	4	M6593
Coexpression	BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS	KRT5 HNRNPA1 HNRNPA2B1	5.70e-05	70	28	3	M40002
Coexpression	BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS	KRT5 HNRNPA1 HNRNPA2B1	8.18e-05	79	28	3	M40003
Coexpression	BENPORATH_SOX2_TARGETS	FAM98A TAF15 ARID1B HNRNPA1 HNRNPA2B1 HNRNPL	1.05e-04	734	28	6	M3835
Coexpression	MURAKAMI_UV_RESPONSE_1HR_UP	KRT1 KRT13	1.15e-04	15	28	2	M13308
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	TAF15 FAM98B HNRNPA1 HNRNPL DHX9	1.32e-04	474	28	5	M40991
Coexpression	MARTENS_TRETINOIN_RESPONSE_DN	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.18e-04	839	28	6	M2099
Coexpression	TIEN_INTESTINE_PROBIOTICS_24HR_UP	HNRNPA0 FAM98A HNRNPH3 DHX9 HNRNPA3	2.88e-04	561	28	5	M1463
CoexpressionAtlas	skin	KRT1 KRT3 KRT5 KRT9 KRT77	8.70e-05	456	22	5	skin
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	FAM98A TAF15 FAM98B HNRNPA2B1 DHX9	1.79e-04	532	22	5	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	PP_MEP_top-relative-expression-ranked_500_k-means-cluster#5	KRT5 KRT13	2.13e-04	21	22	2	PP_MEP_500_K5
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KRT1 KRT3 KRT5 KRT13 KRT76	1.35e-07	196	28	5	03de28e1c963e99623e8b0e33bf2e8ef67dc3baa
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KRT1 KRT3 KRT5 KRT13 KRT76	1.39e-07	197	28	5	e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPA3	1.46e-07	199	28	5	ea75804c34989c99aab542e6d72617ed144819b6
ToppCell	10x5'v1-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 TAF15 HNRNPA1 HNRNPA2B1 HNRNPA3	1.46e-07	199	28	5	713dfd8552635645db5e0b5721c64e5c9b4aa06c
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10\|TCGA-Bladder / Sample_Type by Project: Shred V9	KRTAP6-1 KRTAP20-1 KRTAP19-3 KRTAP20-2	1.25e-06	129	28	4	6a201c6344a015e5cf2f79ccf397fd7ad66b6768
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6\|TCGA-Skin / Sample_Type by Project: Shred V9	KRTAP6-1 KRTAP19-5 KRT77 KRTAP19-3	2.05e-06	146	28	4	522c32103c24fc26836bb5b642083904682d9292
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT1 KRT5 KRT13 HNRNPL	5.24e-06	185	28	4	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	facs-SCAT-Fat-3m\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 KRT13 HNRNPA2B1 HNRNPL	5.59e-06	188	28	4	b8dff61240e5052c2fbf7f28b86fe41822df45b0
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	6.59e-06	196	28	4	6ba02b806d440eed45bad7616bf3b8be57034427
ToppCell	10x5'v1-week_14-16-Lymphocytic_B\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	6.72e-06	197	28	4	31dfd9842410b5c629f39b5130233995dceb0aef
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	6.72e-06	197	28	4	7290f05d0b8465637420119941bcbf2fae44a7e4
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	6.72e-06	197	28	4	78122e1fb80e0ac3084dd4f7c551996330a701df
ToppCell	10x_3'_v3\|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HNRNPA0 HNRNPA2B1 HNRNPL HNRNPA3	6.86e-06	198	28	4	aabb8e9b162ae4cb26ea860c99decdbb51e379e1
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	6.86e-06	198	28	4	a1c8e5c332336823c47c04e56b6d7bc8f057c9da
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 TAF15 HNRNPA2B1 HNRNPA3	7.00e-06	199	28	4	5478b78349b5d8d57f30bb650dcbd5fdb84283d6
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	7.00e-06	199	28	4	8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	7.00e-06	199	28	4	fe3b7d540a644dfc6beea171c809b4d1ba4e188f
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NKX2-3 HNRNPA0 HOXA10 HNRNPA1	7.00e-06	199	28	4	a95aa72387c9558e0316898eaa9df4de8932af1b
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	7.00e-06	199	28	4	8daf945fc93169b0a4fa3ef9f4a87eedd52e314a
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	7.00e-06	199	28	4	cdee798e3586e4e7a15de598239090a85752ea1e
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	7.00e-06	199	28	4	be425e9cb90a73289026b1b7cb581e1c02a8985e
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	7.00e-06	199	28	4	dadee9fc6ce4f4bdb19d29326889316443dda0cb
ToppCell	10x5'v1-week_17-19-Lymphocytic_B\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	7.14e-06	200	28	4	364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	7.14e-06	200	28	4	19a4213f180ac2d29625d140b602a93a74ab3fdd
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	7.14e-06	200	28	4	0fd9a8730b7dc461ddf4586899d363541e72d8ba
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPA3	7.14e-06	200	28	4	c28d4ca51d2e2a3a22784ee251975f16a55b0297
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID1B HNRNPA2B1 HNRNPL HNRNPA3	7.14e-06	200	28	4	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	ARID1B HNRNPA2B1 HNRNPH3 HNRNPA3	7.14e-06	200	28	4	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-7\|TCGA-Breast / Sample_Type by Project: Shred V9	NKX2-3 KRT76 KRT77	4.70e-05	112	28	3	0a2cb8b1339a397e11fcf9e48258bdfa2e89a3ce
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	FAM98B HNRNPA2B1 HNRNPH3	8.37e-05	136	28	3	3e13dc0634f3b05e9f9e6c3193f843f62e603b78
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4\|Hippocampus / BrainAtlas - Mouse McCarroll V32	FAM98B HNRNPA2B1 HNRNPH3	8.37e-05	136	28	3	0185486c39700dd2f72d79be6d283494dd8379c9
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT1 KRT5 KRT77	1.10e-04	149	28	3	d259e9137109eeb2662022f0915ca463f5bebdfe
ToppCell	10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEMP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NKX2-3 HOXA10 HNRNPA1	1.19e-04	153	28	3	14753baa9980f75206fefc3c8b43685fd4178a43
ToppCell	facs-MAT-Fat-24m\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HNRNPA0 KRT1 KRT5	1.26e-04	156	28	3	7433c6d4eb4d061844d8979c1e648d8ed56e1073
ToppCell	TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4\|TCGA-Stomach / Sample_Type by Project: Shred V9	KRT1 KRT3 KRT13	1.28e-04	157	28	3	2553ebf3e48de5bd184e77bd61114faa5a1d95ed
ToppCell	facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX2-3 KRT5 KRT13	1.41e-04	162	28	3	497ae9f86a5e7946d0fde932b35719a382a6b691
ToppCell	facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX2-3 KRT5 KRT13	1.41e-04	162	28	3	7b2949eba2b4aea239d96ed82aafab13b07624eb
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_pDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NKX2-3 HOXA10 KRT5	1.54e-04	167	28	3	8ddf9da71a7c4ed53588435db826563a24cee616
ToppCell	TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-6\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	KRT3 KRT13 KRT76	1.54e-04	167	28	3	4a533972a0f40fff82dccf8e64716cb34f75736e
ToppCell	facs-Heart-RV-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT1 KRT5 KRT13	1.68e-04	172	28	3	a26a73c41e5a05c9dd47a99f3320295f684c5e54
ToppCell	TCGA-Head_and_Esophagus\|World / Sample_Type by Project: Shred V9	KRT1 KRT5 KRT13	1.68e-04	172	28	3	eb18aa179db1818f408c38e442ecfed8582d7dbc
ToppCell	facs-Trachea-nan-18m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT1 KRT5 KRT77	1.76e-04	175	28	3	eb87275da6f61ecb4fbc89421dfd27bead1e0f48
ToppCell	facs-Trachea-nan-18m-Epithelial-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT1 KRT5 KRT77	1.76e-04	175	28	3	3883675a726dd0c6c3a7113d59be2a093ea2dc6f
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HNRNPA0 HNRNPA2B1 HNRNPH3	1.92e-04	180	28	3	ed4966765a6b25456f68185cf0648c4a3a21d7fe
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5\|Hippocampus / BrainAtlas - Mouse McCarroll V32	FAM98B HNRNPA2B1 HNRNPH3	1.92e-04	180	28	3	44988c34861df359a68376500c42a64fbcc4b431
ToppCell	droplet-Skin\|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT1 KRT5 KRT77	2.08e-04	185	28	3	657fd191ed160f8620d57b33820ec7222806f289
ToppCell	facs-Skin-Anagen-3m-Epithelial-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT1 KRT77 HNRNPA3	2.11e-04	186	28	3	9a7932d0a208f3997216bd21a72913cc82b59fc9
ToppCell	facs-Large_Intestine-Distal-24m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HNRNPA0 HOXA10 HNRNPA3	2.11e-04	186	28	3	af038994a6c32261f426b0c40c39be4a9099fe43
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HNRNPA0 KRT5 HNRNPA2B1	2.21e-04	189	28	3	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HNRNPA0 KRT5 HNRNPA1	2.28e-04	191	28	3	4180521a8c5e0ad629cacdd22dc6a94e94b28816
ToppCell	5'\|World / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TAF15 HNRNPA2B1 HNRNPL	2.39e-04	194	28	3	7f98f8bfd17a762a2bf748f1c689c7e941793917
ToppCell	E12.5\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HNRNPA1 HNRNPA2B1 HNRNPA3	2.39e-04	194	28	3	4b335e4da58de1cd94194dc4208ce83854e5e50a
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA1 HNRNPA2B1 HNRNPA3	2.39e-04	194	28	3	f64da5f62e29253d60b9546edf734ba5c17daae1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX2-3 KRT5 KRT13	2.42e-04	195	28	3	17c4d3b59cd0d79ce9ae5dde95586f3e923db16f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX2-3 KRT5 KRT13	2.42e-04	195	28	3	66caa5c063184e7d3d653c8f6c289555cb36fa82
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX2-3 KRT5 KRT13	2.42e-04	195	28	3	ed74c113074fb5d3c42f2330b0e6042d32c3611a
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPA0 HOXA10 HNRNPA1	2.46e-04	196	28	3	fd0a2b863dedaf08d18e7f67da18ac7e853991e4
ToppCell	10x5'v1-week_17-19\|World / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 TAF15 HNRNPA2B1	2.46e-04	196	28	3	31229affb48521e8be93b6061178fd8cea09ba99
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPA0 HOXA10 HNRNPA1	2.50e-04	197	28	3	9af431323da6d099459b7360af40e5df998cffbd
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPA0 HOXA10 HNRNPA1	2.50e-04	197	28	3	5f6fce382f273e789ffbb75b63e9b4e87519918e
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	ARID1B HNRNPL HNRNPA3	2.50e-04	197	28	3	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA1 HNRNPA2B1 HNRNPA3	2.50e-04	197	28	3	106b0f9a0425facc634feb7498c9ba2c55edfbf8
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NKX2-3 HOXA10 HNRNPA1	2.50e-04	197	28	3	ad6c200a193a15360d17463e18a465ce1b90b8da
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPA0 HOXA10 HNRNPA1	2.50e-04	197	28	3	fc718a254bda4df2d62975d04393492fb75ab305
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPA0 HOXA10 HNRNPA1	2.50e-04	197	28	3	c7b33d64e5cba3a8fc6f2d6aa85ebc83893195de
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KRT5 KRT13 KRT76	2.50e-04	197	28	3	d968d7d5608b175bb567ea3a315bf473ec3be459
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA2B1 HNRNPA3	2.54e-04	198	28	3	8aa4149d2c1cec73cfd654db093252ec8ec5ef68
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KRT3 KRT5 KRT13	2.54e-04	198	28	3	f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell	PBMC_fresh-frozen\|World / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARID1B HNRNPA1 HNRNPA2B1	2.54e-04	198	28	3	dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	ARID1B HNRNPL HNRNPA3	2.54e-04	198	28	3	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARID1B HNRNPL HNRNPA3	2.54e-04	198	28	3	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HNRNPA0 HNRNPA1 HNRNPA2B1	2.54e-04	198	28	3	cd876fba12ff30b74aa507286cb1f3a867011a92
ToppCell	cycling_basal_cell\|World / shred by cell class for bronchial biopsy	KRT5 HNRNPA1 HNRNPA2B1	2.54e-04	198	28	3	d5306121a75c5eb37d62c353799a98e6ba5ab63f
ToppCell	3'-GW_trimst-1-LargeIntestine\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPA0 HOXA10 HNRNPA1	2.54e-04	198	28	3	ea6621a148a96c8ffa1a93a35c9e288545d2637a
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HNRNPA1 HNRNPA2B1 HNRNPL	2.54e-04	198	28	3	a07307ecc3d86fbcaf7369b7fce60334b7e2dc8f
ToppCell	(2)_MNPs-(2)_Dendritic_Cells\|(2)_MNPs / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	HNRNPA0 HNRNPA1 HNRNPA3	2.54e-04	198	28	3	4c1f155298b7d0afddfeb2744b369a1ffd823916
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPA0 HOXA10 HNRNPA1	2.54e-04	198	28	3	a883e25cb7a78b2ecfb15cef4633bdd02dfafb12
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Early_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	HNRNPA2B1 HNRNPH3 HNRNPL	2.57e-04	199	28	3	d67f5ae05daf942fb79f5b962021f37f4e275f4d
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPA0 HOXA10 HNRNPA1	2.57e-04	199	28	3	bb201deb281619113edcd1de2af2d3eb21b967b8
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPA0 HNRNPA1 HNRNPA3	2.57e-04	199	28	3	99778178e3ec121802db938db8c5475d19b43fec
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPA0 HOXA10 HNRNPA1	2.57e-04	199	28	3	c007cd51577e31553395ceaed70ad447e5854546
ToppCell	3'-GW_trimst-1\|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NKX2-3 HNRNPA0 HNRNPA1	2.57e-04	199	28	3	ecfb6381e2971a3e355e661a6df0021914485e74
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPA1 HNRNPA2B1 HNRNPA3	2.61e-04	200	28	3	4234bdc70a9941d4bf77148d75bd271e0c114b88
ToppCell	Kidney-Keratinocytes\|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.	KRT1 KRT5 KRT77	2.61e-04	200	28	3	41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d
ToppCell	severe\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HNRNPA2B1 HNRNPH3 HNRNPA3	2.61e-04	200	28	3	accc618d6b960bff30cb531c1226295bfc8650f6
ToppCell	Sepsis-Bac-SEP\|Sepsis / Disease, condition lineage and cell class	HNRNPA0 HNRNPA1 HNRNPA2B1	2.61e-04	200	28	3	1f80e6a49c632b3ba0cdac1225c78e5d6d6d78a5
ToppCell	Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Fgf10_(Lateral_dorsal_thalamic_nuclei_(LD))\|Thalamus / BrainAtlas - Mouse McCarroll V32	NKX2-3 HOXA10	2.87e-04	40	28	2	c645fd6bebf8a6c5aa6ff9d40105a3d65695496b
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1-Inhibitory_Neuron.Gad1Gad2_Sst.Grm1_(Interneuron,_OLM3_(CA1_enriched?))\|Hippocampus / BrainAtlas - Mouse McCarroll V32	HOXA10 KRT13	5.43e-04	55	28	2	a55d3edca2dd9ca7a703b2b3a5941b30b5f0a6df
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1-Inhibitory_Neuron.Gad1Gad2_Sst.Grm1_(Interneuron,_OLM3_(CA1_enriched?))-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	HOXA10 KRT13	5.43e-04	55	28	2	10e98fc862d89141512bdebae1231ef1a82105b0
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	HOXA10 KRT13	5.43e-04	55	28	2	bac333ea3914a49376105dd977a0b8493b0d2001
ToppCell	Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.C1ql3_(Hippocampus_Excitatory_Neuron)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	KRT9 KRT77	1.68e-03	97	28	2	1da964954a95c497ac4a24df1ea3575df5747025
ToppCell	Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	KRT9 KRT77	1.68e-03	97	28	2	dd188763ba02337e4f25d56766eda886cffa810d
ToppCell	Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	KRT9 KRT77	1.68e-03	97	28	2	a0242258aad0766450ff52fe28278cbb2b8d63a0
ToppCell	Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.C1ql3_(Hippocampus_Excitatory_Neuron)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	KRT9 KRT77	1.68e-03	97	28	2	98a31b9bf0adcad1cb1d803bf7a23d49b4e1f2d5
ToppCell	PND07-28-samps-Myeloid-Macrophage-macrophage-A\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	KRT1 KRT5	2.23e-03	112	28	2	d21cfcb04a27cc9fb74e0c2afa8a8cdfb886ae21
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_Synovial_Sarcoma\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	KRT13 KRTAP19-3	2.30e-03	114	28	2	674d34a35f403ba938a2a109a68bf34bdc3657c9
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_Synovial_Sarcoma-3\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	KRT13 KRTAP19-3	2.30e-03	114	28	2	cbed6161fc307056ef1ac08b0f62c8c544866884
ToppCell	TCGA-Brain-Recurrent_Tumor-Low_Grade_Glioma-Oligodendroglioma-7\|TCGA-Brain / Sample_Type by Project: Shred V9	NKX2-3 KRT1	2.47e-03	118	28	2	42aa4d8975cec034802ff94aa8867d70c0a4d7b8
ToppCell	droplet-Skin-nan-18m-Epithelial-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HOXA10 KRT76	2.63e-03	122	28	2	c7e81504e62d132624ec15b7d38dc5b6493a37a4
ToppCell	droplet-Skin-nan-18m-Epithelial\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HOXA10 KRT76	2.63e-03	122	28	2	8f675dc341b3f6e22f7e52c34d167d9e37df0982
Computational	Neighborhood of DDX5	HNRNPA1 HNRNPA2B1 HNRNPL DHX9	2.10e-06	65	16	4	GCM_DDX5
Computational	Keratin.	KRT1 KRT5 KRT13	6.89e-06	26	16	3	MODULE_298
Computational	Genes in the cancer module 68.	KRT1 KRT5 KRT13	6.89e-06	26	16	3	MODULE_68
Computational	Genes in the cancer module 153.	KRT1 KRT5 KRT13	1.57e-05	34	16	3	MODULE_153
Computational	RNA splicing.	HNRNPA0 HNRNPA1 HNRNPA2B1	1.12e-04	65	16	3	MODULE_183
Computational	Intermediate filaments.	KRT1 KRT5 KRT13	1.71e-04	75	16	3	MODULE_154
Computational	Genes in the cancer module 297.	KRT1 KRT5 KRT13	2.07e-04	80	16	3	MODULE_297
Computational	Intermediate filaments and keratins.	KRT1 KRT5 KRT13	2.07e-04	80	16	3	MODULE_357
Computational	Genes in the cancer module 32.	HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPL	3.63e-04	241	16	4	MODULE_32
Computational	Neighborhood of ACTG1	HNRNPA1 HNRNPA2B1 DHX9	7.52e-04	124	16	3	GCM_ACTG1
Computational	Neighborhood of MSN	HNRNPL DHX9	7.68e-04	28	16	2	GCM_MSN
Computational	Neighborhood of CDC10	HNRNPA2B1 HNRNPH3 HNRNPL	1.21e-03	146	16	3	MORF_CDC10
Computational	Neighborhood of ANP32B	HNRNPA1 HNRNPL	1.27e-03	36	16	2	GCM_ANP32B
Computational	Neighborhood of SMARCC1	HNRNPL DHX9	1.34e-03	37	16	2	GCM_SMARCC1
Computational	Neighborhood of RAF1	HNRNPA1 HNRNPL	1.81e-03	43	16	2	GCM_RAF1
Computational	Genes upregulated in subsets of cells of a given type within various tumors	KRT1 KRT13	2.44e-03	50	16	2	GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN
Computational	Neighborhood of DENR	HNRNPA1 HNRNPH3	2.54e-03	51	16	2	GNF2_DENR
Computational	Intermediate filaments and MT.	KRT5 KRT13	4.47e-03	68	16	2	MODULE_438
Computational	Neighborhood of CBFB	HNRNPL DHX9	4.73e-03	70	16	2	GCM_CBFB
Computational	Neighborhood of RBBP6	HNRNPA1 HNRNPH3	4.73e-03	70	16	2	GNF2_RBBP6
Computational	Neighborhood of NPM1	HNRNPA1 HNRNPA2B1	5.00e-03	72	16	2	GNF2_NPM1
Drug	teleocidin B	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	9.17e-11	123	27	7	CID000072425
Drug	sulfur mustard	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	1.36e-10	130	27	7	CID000010461
Drug	homocysteine thiolactone	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	1.43e-10	131	27	7	CID000107712
Drug	al-Badry	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	7.26e-10	165	27	7	CID000004545
Drug	phenyl isocyanate	KRT1 KRT5 KRT9	2.97e-08	6	27	3	ctd:C025319
Drug	AC1L9MJT	KRT1 KRT3 KRT5 KRT9 KRT13 KRT77	8.49e-08	192	27	6	CID000448959
Drug	AC1L1GT5	KRT1 KRT5 KRT9 KRT13 KRTAP6-1	8.54e-08	95	27	5	CID000003829
Drug	Velcade (bortezomib	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	2.04e-07	374	27	7	CID000093860
Drug	bromovanin	KRT9 HNRNPA1 KRT77 HNRNPL HNRNPA3	3.65e-07	127	27	5	ctd:C515564
Drug	SK&F 83959	HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	9.19e-07	153	27	5	ctd:C080703
Drug	1-2q	KRT1 KRT3 KRT5 KRT9 KRT13 KRT77	9.39e-07	289	27	6	CID000011820
Drug	AC1L1AUZ	HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.04e-06	157	27	5	CID000001160
Drug	AC1NRA5C	HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.73e-06	174	27	5	CID005287709
Drug	olomoucine II	KRT5 KRT9 KRT13	4.27e-06	27	27	3	CID005494414
Drug	adenosine 3',5'-cyclic phosphate	SHANK1 KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	6.95e-06	907	27	8	CID000000274
Drug	I5B1	KRT1 KRT5 KRT13	1.12e-05	37	27	3	CID005487705
Drug	2,4-diacetylphloroglucinol	KRT1 KRT5 KRT9	1.91e-05	44	27	3	CID000016547
Drug	ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid	KRT5 KRT13	2.03e-05	6	27	2	ctd:C034814
Drug	ClOClO	KRT1 KRT5	2.03e-05	6	27	2	CID000517862
Drug	butyrate	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	2.36e-05	767	27	7	CID000000264
Drug	ClOO	KRT1 KRT5	2.83e-05	7	27	2	CID005460593
Drug	2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine	HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	3.91e-05	163	27	4	ctd:D015647
Drug	phenyl saligenin phosphate	KRT1 KRT5 KRT9	3.95e-05	56	27	3	CID000104885
Drug	CK 6	KRT3 KRT5 KRT13	4.39e-05	58	27	3	CID000447960
Drug	ClOOCl	KRT1 KRT5	6.06e-05	10	27	2	CID000123287
Drug	ethylnylestradiol	HOXA10 KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77	7.05e-05	1251	27	8	CID000003285
Drug	K 2S	KRT1 KRT76	1.05e-04	13	27	2	CID000014800
Drug	1pxm	KRT1 KRT5 KRT13	1.07e-04	78	27	3	CID000447959
Drug	3-deoxy-3-fluoro-D-glucose	KRT1 KRT5	1.41e-04	15	27	2	CID000450201
Drug	phorbol acetate myristate	KRT1 KRT3 KRT5 KRT9 KRT13 KRT76 KRT77 HNRNPH3	1.54e-04	1399	27	8	CID000004792
Drug	bilirubin-phosphate	KRT1 KRT5	1.61e-04	16	27	2	CID005497144
Drug	AC1L1B55	HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	1.73e-04	454	27	5	CID000001287
Drug	K-11	KRT1 KRT9	1.82e-04	17	27	2	CID000469667
Drug	potassiopotassium	KRT1 KRT5 KRT9	1.86e-04	94	27	3	CID006432276
Drug	AC1L9LFK	KRT1 KRT3	2.29e-04	19	27	2	CID000447957
Drug	genistein	HOXA10 KRT5 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPL HNRNPA3	2.51e-04	1117	27	7	CID005280961
Drug	AC1NPJ0T	KRT1 KRT5	2.54e-04	20	27	2	CID005159168
Drug	AC1L9H5I	KRT1 KRT9	4.67e-04	27	27	2	CID000444945
Drug	Bi-E	KRT1 KRT9	4.67e-04	27	27	2	CID006914595
Drug	AC1NQZM2	KRT1 KRT5	5.39e-04	29	27	2	CID005282177
Disease	Palmoplantar keratoderma, epidermolytic	KRT1 KRT9	5.81e-07	2	23	2	cv:C1721006
Disease	Keratosis of Greither	KRT1 KRT9	5.81e-07	2	23	2	C2936837
Disease	Keratoderma, Palmoplantar, Epidermolytic	KRT1 KRT9	1.74e-06	3	23	2	C1721006
Disease	Epidermolytic palmoplantar keratoderma Vorner type	KRT1 KRT9	1.74e-06	3	23	2	C2931735
Disease	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	HNRNPA1 HNRNPA2B1	1.74e-06	3	23	2	cv:C1833662
Disease	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA	HNRNPA1 HNRNPA2B1	1.74e-06	3	23	2	C1833662
Disease	Epidermolytic palmoplantar keratoderma of Vorner	KRT1 KRT9	1.74e-06	3	23	2	C0343110
Disease	myopathy (implicated_via_orthology)	HNRNPA1 HNRNPA2B1 HNRNPA3	6.99e-06	48	23	3	DOID:423 (implicated_via_orthology)
Disease	autosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology)	HNRNPA1 HNRNPA3	8.70e-06	6	23	2	DOID:0110306 (implicated_via_orthology)
Disease	Amyotrophic Lateral Sclerosis	TAF15 HNRNPA1 HNRNPA2B1	1.24e-05	58	23	3	C0002736
Disease	Keratoderma, Palmoplantar	KRT1 KRT9	6.93e-05	16	23	2	C4551675
Disease	neurodegenerative disease (implicated_via_orthology)	HNRNPA1 HNRNPA2B1 HNRNPA3	1.92e-04	145	23	3	DOID:1289 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	KRT5 ARID1B KRT76 KRTAP20-1 HNRNPL	1.23e-03	1074	23	5	C0006142

Protein segments in the cluster

Peptide	Gene	Start	Entry
GGGGGYGGSSAGYGV	ARID1B	436	Q8NFD5
GGYGGDRSGGGYGGD	TAF15	416	Q92804
SGGGYGGDRGGGYGG	TAF15	451	Q92804
GGGSGYGGDRSGGYG	TAF15	536	Q92804
SGGYGGDRSGGGYGG	TAF15	546	Q92804
AGGYGGGFGGSYGGG	KRT76	91	Q01546
GGSFGYSYGGGSGGG	KRT9	66	P35527
SYGGGGSGGGYGGGS	KRT9	496	P35527
GSGCGYGGYGYGSGF	KRTAP19-1	36	Q8IUB9
GSYGYGSGFGGYGYG	KRTAP19-1	51	Q8IUB9
GSGFGGYGYGSGFGG	KRTAP19-1	56	Q8IUB9
GYGYGSGFGGYGYGC	KRTAP19-1	61	Q8IUB9
GSGCGYGGYGYGSGF	KRTAP19-3	36	Q7Z4W3
GGYGYGSGFGGYGYG	KRTAP19-3	51	Q7Z4W3
GGYGGGFGSGYGGGF	KRT3	91	P12035
GGYGGGYGGGMGGGL	KRT3	536	P12035
GYGSGSGYGGGLGGG	KRT5	501	P13647
FGGGYGGGLGGGYGG	KRT13	61	P13646
GYGGGYGGYGYGSGF	KRTAP19-5	36	Q3LI72
GGGFGGGGYGGGYGP	KRT1	131	P04264
YGRGGGGSGGYYGQG	HNRNPH3	321	P31942
GGSGGYYGQGGMSGG	HNRNPH3	326	P31942
GGGAGGGGGGGYYAH	HOXA10	46	P31260
GDYGGRGGYGGRGGY	FAM98B	391	Q52LJ0
GGRGYGDPYGGGGGG	FAM98B	406	Q52LJ0
AAAGGGGGGGRYYGG	HNRNPL	36	P14866
GGGGGRYYGGGSEGG	HNRNPL	41	P14866
GGLGYGYGGLGCGYG	KRTAP6-1	21	Q3LI64
SYYGGLGYGYGGFGG	KRTAP19-8	6	Q3LI54
LGYGYGGFGGWGYGY	KRTAP19-8	11	Q3LI54
GGFGGWGYGYGCGYG	KRTAP19-8	16	Q3LI54
GYGCGYGGYGGYGNG	KRTAP20-1	26	Q3LI63
GYGGLGCGYGRGYGG	KRTAP20-2	31	Q3LI61
YGCAYPAGGGGGGGG	NKX2-3	291	Q8TAU0
SGGGYGGGYSSGGYG	DHX9	1181	Q08211
GGGYSSGGYGSGGYG	DHX9	1186	Q08211
GGSGGGGGYQDGGYR	FAM98A	386	Q8NCA5
GGHSSGGYQGGGYGG	FAM98A	411	Q8NCA5
GGYGAGSRAYGGGGG	SHANK1	1311	Q9Y566
GDGYNGYGGGPGGGN	HNRNPA2B1	241	P22626
RGGYGGGGPGYGNQG	HNRNPA2B1	266	P22626
GGGPGYGNQGGGYGG	HNRNPA2B1	271	P22626
YGGGNYGPGGSGGSG	HNRNPA2B1	331	P22626
YGPGGSGGSGGYGGR	HNRNPA2B1	336	P22626
KGGGGGYNSYGGYGG	HNRNPA0	211	Q13151
GYNSYGGYGGGGGGG	HNRNPA0	216	Q13151
GGYGGGGGGGYNAYG	HNRNPA0	221	Q13151
GGGGGYNAYGGGGGG	HNRNPA0	226	Q13151
GYNGFGGDGGNYGGG	HNRNPA3	266	P51991
RGGYGGGGPGYGNQG	HNRNPA3	286	P51991
GGGPGYGNQGGGYGG	HNRNPA3	291	P51991
YGNQGGGYGGGGGYD	HNRNPA3	296	P51991
GGYGGGGGYDGYNEG	HNRNPA3	301	P51991
GGGYGSGGGSGGYGS	HNRNPA3	361	P51991
GFGNDGGYGGGGPGY	HNRNPA1	246	P09651
GGYGGGGPGYSGGSR	HNRNPA1	251	P09651
GGGGSYGSGGYGGGS	KRT77	501	Q7Z794
YGSGGYGGGSGGGYG	KRT77	506	Q7Z794
YGGGSGGGYGGGRSY	KRT77	511	Q7Z794
GGYGSGCGGGGGSYG	KRT77	536	Q7Z794